Asian Spectator


The Times

.

As A Breakthrough Drug For The Expansive Osteoporosis Market, Bogutai® (Teriparatide Injection) Has Been Officially Approved By The China National Medical Products Administration (NMPA)

HONG KONG SAR - EQS Newswire - 22 January 2024 - Uni-Bio Science Group Limited ("Uni-Bio", the "Company", together with its subsidiaries, the "Group"), a leading biopharmaceutical company, is excited to announce that the China National Medical Products Administration ("NMPA") has officially approved the marketing application for BOGUTAI® (teriparatide injection) on January 16, 2024, with the approval number "国药准字S20240004".

Magazine

Compressed Air Pipe and Fittings: What Every Australian Industrial Facility Needs to Know

Compressed air is the fourth utility of modern industry, right alongside electricity, gas, and water. Yet despite its critical role in powering everything from pneumatic tools to automated productio...

Common Risks Hidden in Commercial Lease Agreements

Commercial leases are often longer and more complex than tenants expect, and the fine print can carry significant financial and operational consequences over the years that follow. Many business own...

Corporate Secretarial Services in Singapore: Annual Compliance, Key Filings, and Common Mistake

Annual compliance in Singapore should not be treated as a once-a-year administrative event. It is an ongoing governance system that depends on accurate records, timely filings, disciplined approvals...

hacklink hack forum hacklink film izle hacklink z-libraryagen bolatelegram下载betwoonGanobetzlibrary.jojobetสล็อตสล็อตgrandpashabetstakejojobetTotalSportStreamEasthitbet girişbetasusjojobetjojobetholiganbetvipparkGalabetDizipalStreamEastPadişahbetgrandpashabetGalabetchild porngrandpashabetjojobetmostbet